Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

Magnetic Resonance Spectroscopy 59 Cyclophosphamide 44 pembrolizumab 34 Radiotherapy 30 fludarabine 27 Nivolumab 26 Biopsy 26 Metformin 22 Fluorodeoxyglucose F18 22 Specimen Handling 20 Bevacizumab 20 Temozolomide 17 Radiosurgery 17 Cisplatin 16 Carboplatin 14 Fluorouracil 13 Dexamethasone 13 Paclitaxel 12 Gemcitabine 12 Etoposide 12 gallium 68 PSMA-11 11 durvalumab 11 X-Rays 11 Surgical Procedures, Operative 11 Radiation 11 Positron Emission Tomography Computed Tomography 11 Letrozole 11 Irinotecan 11 Ipilimumab 11 Surveys and Questionnaires 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × OTHER × molgramostim × Clear all

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡